Literature DB >> 2272363

Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats.

J Kamei1, H Tanihara, Y Kasuya.   

Abstract

The effects of highly selective agonists of kappa-opioid receptors, namely U-50,488H and U-62,066E, on the capsaicin-induced cough reflex in rats were studied. Intracisternal (i.cist.) injection of U-50,488H and of U-62,066E significantly decreased the number of coughs in a dose-dependent manner. The antitussive potency of i.cist. injection of these two kappa-opioid agonists was similar to that of morphine. Intraperitoneal (i.p.) injection of U-50,488H and of U-62,066E also decreased the number of coughs, again in a dose-dependent manner. The antitussive effects of U-50,488H and U-62,066E were blocked by norbinaltorphimine, an antagonist of kappa-opioid receptors. Methysergide, administered i.cist. (3 nmol), antagonized the antitussive effects of U-50,488H and U-62,066E. However, ketanserin had no effect on the antitussive effects of these kappa-opioid agonists. These data suggest that U-50,488H and U-62,066E exert their antitussive effect on rats through stimulation of kappa-opioid receptors. Furthermore, with respect to the antitussive effects of kappa-opioid agonists, the system that involves 5-HT1 receptors may be more important than the system that involves 5-HT2 receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2272363     DOI: 10.1016/0014-2999(90)90014-w

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Involvement of mu-opioid receptors in the antitussive effects of pentazocine.

Authors:  J Kamei; K Katsuma; Y Kasuya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

2.  Diaphragm motor unit recruitment in rats.

Authors:  Carlos B Mantilla; Yasin B Seven; Wen-Zhi Zhan; Gary C Sieck
Journal:  Respir Physiol Neurobiol       Date:  2010-07-08       Impact factor: 1.931

3.  The clinical effective dose of alfentanil for suppressing cough during emergence from desflurane anesthesia.

Authors:  Mi Geum Lee; Young Jin Chang; Jong Min Park; Hee-Yeon Park
Journal:  Korean J Anesthesiol       Date:  2011-10-22

4.  Target controlled remifentanil infusion for smooth laryngeal mask airway removal during emergence from desflurane-remifentanil anesthesia.

Authors:  Derya Ozkan; Julide Ergil; Alp Alptekin; Nihan Aktürk; Haluk Gümüs
Journal:  J Anesth       Date:  2012-02-12       Impact factor: 2.078

5.  Serotonin involvement in the discriminative stimulus effects of kappa opioids in pigeons.

Authors:  M E Bronson; Y P Lin; K Burchett; M J Picker; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Low dose of fentanyl reduces predicted effect-site concentration of propofol for flexible laryngeal mask airway insertion.

Authors:  Junko Yumura; Yoshihiko Koukita; Ken-ichi Fukuda; Yuzuru Kaneko; Tatsuya Ichinohe
Journal:  J Anesth       Date:  2009-05-15       Impact factor: 2.078

7.  Modulation of capsaicin induced airway reflexes in humans: effect of monoamine oxidase inhibition.

Authors:  N B Choudry; J Studham; D Harland; R W Fuller
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

Review 8.  Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors.

Authors:  Jolien De Neve; Thomas M A Barlow; Dirk Tourwé; Frédéric Bihel; Frédéric Simonin; Steven Ballet
Journal:  RSC Med Chem       Date:  2021-04-21

9.  Antitussive, expectorant and analgesic effects of the ethanol seed extract of Picralima nitida (Stapf) Th. & H. Durand.

Authors:  Gabriel Dapaah; George Asumeng Koffuor; Priscilla Kolibea Mante; Inemesit Okon Ben
Journal:  Res Pharm Sci       Date:  2016 Mar-Apr

10.  Butorphanol suppresses fentanyl-induced cough during general anesthesia induction: A randomized, double-blinded, placebo-controlled clinical trial.

Authors:  Xiao-Yan Cheng; Xiao-Qin Lun; Hong-Bo Li; Zhi-Jie Zhang
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.